NuVasive

2 results

Mainstay Medical’s  ReActiv8 device for the treatment of chronic low back pain

Mainstay Medical has passed an “important milestone” on winning access to the key US market for its new implant therapy for people suffering from chro(...)

The study indicates that 77 per cent of medtech firms expect sales to rise over the next three months

Four out of five Irish-based medical technology firms expect sales to rise over the next year with many companies planning to take on additional staff(...)